About · Munich · 2026

Founder, investor, systems thinker.

I map the broken system of ovarian aging and design the infrastructure women need to extend their healthspan. I'm a systems thinker more than a specialist. My work is translation: turning what the science knows into frameworks women can use, and into the market case founders and investors need to act on.

Who I am

I'm a German founder and systems thinker focused on reproductive longevity. I see ovarian aging as an entry point to longevity science, not a niche fertility issue.

My work centers on one core insight: the ovaries are not just reproductive organs. They are a central system of female health. They influence cardiovascular health, brain function, bone density, metabolism, and overall aging. Yet they begin to decline decades before other organs, and this systemic impact has been largely overlooked.

I call myself the Reproductive Longevity Architect because the problem is structural. The science is moving. What slows it down is everything around the science: how research gets funded, how trials get designed, whether findings reach a clinic, whether a woman can afford what works. That is the system I work on.

I co-founded YUEVA Longevity as my current vehicle for turning these insights into real-world experiments and solutions.

Who inspires me

Some of the voices I follow.

Not an exhaustive list. A few of the people whose work has shaped how I think about this field.

Chiara Herzog

Scientist · Cambridge

Co-developed the WID tests, which detect women-specific cancers from a single sample, and helped build the field's framework for validating biomarkers of aging.

Jennifer Garrison

Scientist · Buck Institute

Directs the Global Consortium for Reproductive Longevity and Equality. The clearest academic voice making the case that ovarian aging belongs in longevity science.

Natalie Crawford

OB/GYN · Fora Fertility

Reproductive endocrinologist and author who has made fertility science genuinely clear and usable for women in their 30s.

Kayla Barnes-Lentz

Longevity · n=1

Documents female-specific longevity protocols in public and in detail, with herself as the subject.

Alexandra Bause

Investor · Apollo Health Ventures

Backs companies targeting the biology of aging. A rigorous read on where longevity capital is moving.

If we're at the same intersection, let's talk.

Investors, founders, scientists, operators at the reproductive-longevity edge — DMs open.

Start a conversation → Read the essays